NCT01735344View on ClinicalTrials.gov

Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Fed
Interventions
DRUG

Lisinopril Tablets 40 mg

40 mg tablet once a day

DRUG

Lisinopril

40 mg tablet once a day

Trial Locations (1)

Unknown

Accutest Research Lab (I) Pvt. Ltd., Navi-Mumbai

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY